Reckitt shares jump after US jury backs Mead Johnson in formula case
Reckitt shares rose 5% after a U.S. jury backed its unit Mead Johnson in a baby formula lawsuit alleging Enfamil preterm formula caused serious bowel disease.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.